Skip to content
PubMed This is a summary of 56 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 56 referenced papers

Top Authors

Hironobu Ihn
The University of Tokyo
E.M.G.J. de Jong
Radboud University Medical Center
Jorre S. Mertens
University Medical Center Utrecht
Ruth Ann Vleugels
Brigham and Women's Hospital
Ariane L. Herrick
Manchester Academic Health Science Centre
Andreas D. Hartkopf
University of Tübingen
Sara Y. Brucker
University of Tübingen
Alisa N. Femia
New York University
Christopher P. Denton
University College London
Michael Hughes
Royal Hallamshire Hospital

Top Institutions

Ranked by publications Top 10 institutions

References

References (56)
  1. 1

    [Eosinophilic fasciitis (Shulman's disease): Diagnostic and therapeutic review].

    Sène D

    La Revue de medecine interne 2015; (36(11)):738-45.

    PMID: 26385125
  2. 2

    Paraneoplastic eosinophilic fasciitis with generalized morphea and vitiligo in a patient working with organic solvents.

    Hanami Y, Ohtsuka M, Yamamoto T

    The Journal of dermatology 2016; (43(1)):67-8 doi:10.1111/1346-8138.13174.

    PMID: 26507670
  3. 3

    Correspondence: The association between morphea profunda and monoclonal gammopathy: A case series.

    Endo J, Strickland N, Grewal S, et al.

    Dermatology online journal 2016; (22(3)).

    PMID: 27136633
  4. 4

    Juvenile eosinophilic fasciitis: three case reports with review of the literature.

    Papa R, Nozza P, Granata C, et al.

    Clinical and experimental rheumatology 2016; (34(3)):527-30.

    PMID: 27268780
  5. 5

    Successful treatment of aplastic anemia-paroxysmal nocturnal hemoglobinuria associated with eosinophilic fasciitis with matched unrelated donor allogeneic peripheral blood stem cell transplantation.

    Sasaki K, Popat U, Jain P, et al.

    Clinical case reports 2016; (4(8)):765-7 doi:10.1002/ccr3.613.

    PMID: 27525080
  6. 6

    Eosinophilic fasciitis with subjacent myositis.

    Whitlock JB, Dimberg EL, Selcen D, Rubin DI

    Muscle & nerve 2017; (56(3)):525-529 doi:10.1002/mus.25492.

    PMID: 27875630
  7. 7

    Eosinophilic fasciitis.

    Lamback EB, Resende FS, Lenzi TC

    Anais brasileiros de dermatologia 2016; (91(5 suppl 1)):57-59 doi:10.1590/abd1806-4841.20164683.

    PMID: 28300895
  8. 8

    Morphea and Eosinophilic Fasciitis: An Update.

    Mertens JS, Seyger MMB, Thurlings RM, et al.

    American journal of clinical dermatology 2017; (18(4)):491-512 doi:10.1007/s40257-017-0269-x.

    PMID: 28303481
  9. 9

    [Eosinophilia heralding the diagnosis of eosinophilic fasciitis (Shulman's disease)].

    Ernest V, Sautereau N, Masson E, et al.

    La Revue de medecine interne 2017; (38(12)):840-843 doi:10.1016/j.revmed.2017.07.010.

    PMID: 28867532
  10. 10

    Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis.

    Jinnin M, Yamamoto T, Asano Y, et al.

    The Journal of dermatology 2018; (45(8)):881-890 doi:10.1111/1346-8138.14160.

    PMID: 29235676
  11. 11

    Neuromuscular ultrasound findings in eosinophilic fasciitis: A case series and literature review.

    Verenes M, Stone SL, Hobson-Webb LD, et al.

    Muscle & nerve 2018; (58(2)):E15-E18 doi:10.1002/mus.26150.

    PMID: 29679393
  12. 12

    Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission.

    Tull R, Hoover WD, De Luca JF, et al.

    Drugs in context 2018; (7()):212529 doi:10.7573/dic.212529.

    PMID: 30302114
  13. 13

    Eosinophilic fasciitis: an atypical presentation of a rare disease.

    Cabral C, Novais A, Araujo D, et al.

    Revista da Associacao Medica Brasileira (1992) 2019; (65(3)):326-329 doi:10.1590/1806-9282.65.3.326.

    PMID: 30994827
  14. 14

    Lessons of the month 2: Connecting the clues: limb swelling and pain.

    Prossor T, Sriskandarajah K, Vonberg FW, Dani M

    Clinical medicine (London, England) 2020; (20(1)):105-106 doi:10.7861/clinmed.2019-0293.

    PMID: 31941742
  15. 15

    A case of eosinophilic fasciitis and generalized morphea overlap.

    Watanabe Y, Yamamoto M, Yamamoto T

    Dermatology online journal 2020; (26(2)).

    PMID: 32239898
  16. 16

    Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression.

    Bui AN, Nelson CA, Lian CG, et al.

    JAAD case reports 2020; (6(8)):693-696 doi:10.1016/j.jdcr.2020.04.010.

    PMID: 32715051
  17. 17

    Characteristics of Japanese patients with eosinophilic fasciitis: A brief multicenter study.

    Yamamoto T, Ito T, Asano Y, et al.

    The Journal of dermatology 2020; (47(12)):1391-1394 doi:10.1111/1346-8138.15561.

    PMID: 32860239
  18. 18

    Atypical Presenting Symptoms of Acute Onset Acquired Haemophilia with Eosinophilic Fasciitis.

    Nakakubo Y, Yamamoto K, Fujita M

    European journal of case reports in internal medicine 2020; (7(9)):001722 doi:10.12890/2020_001722.

    PMID: 32908832
  19. 19

    A "groovy" diagnosis: Eosinophilic fasciitis.

    Korsten P

    Clinical case reports 2020; (8(12)):3545-3546 doi:10.1002/ccr3.3128.

    PMID: 33363970
  20. 20

    Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review.

    Moreno-Arquieta IA, Cardenas-de la Garza JA, Esquivel-Valerio JA, et al.

    The Journal of dermatological treatment 2022; (33(3)):1765-1768 doi:10.1080/09546634.2021.1890682.

    PMID: 33615948
  21. 21

    The place of 18F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report.

    Belfeki N, Louarn N, Chouchane I, et al.

    Reumatismo 2021; (72(4)):252-254 doi:10.4081/reumatismo.2020.1353.

    PMID: 33677952
  22. 22

    Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review.

    Kougkas N, Bertsias G, Papalopoulos I, et al.

    Rheumatology international 2021; (41(10)):1833-1837 doi:10.1007/s00296-021-04887-3.

    PMID: 34009397
  23. 23

    Complete reversibility of pembrolizumab-induced eosinophilic fasciitis without corticosteroids: A case report.

    Bourcier L, St-Hilaire È, LeBlanc M, Picard L

    SAGE open medical case reports 2021; (9()):2050313X211025111 doi:10.1177/2050313X211025111.

    PMID: 34178352
  24. 24

    Groove Sign in Eosinophilic Fasciitis.

    Mourad AI, Lehman JS, Mydlarski PR

    Mayo Clinic proceedings 2021; (96(8)):2184 doi:10.1016/j.mayocp.2021.04.001.

    PMID: 34353471
  25. 25

    Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy.

    Boppana SH, Dulla NR, Beutler BD, et al.

    The American journal of case reports 2021; (22()):e932888 doi:10.12659/AJCR.932888.

    PMID: 34403405
  26. 26

    Diagnosis and treatment of eosinophilic fasciitis: Report of two cases.

    Song Y, Zhang N, Yu Y

    World journal of clinical cases 2021; (9(29)):8831-8838 doi:10.12998/wjcc.v9.i29.8831.

    PMID: 34734063
  27. 27

    Controversy around the morphea.

    Dańczak-Pazdrowska A, Cieplewicz P, Żaba R, et al.

    Postepy dermatologii i alergologii 2021; (38(5)):716-720 doi:10.5114/ada.2021.106242.

    PMID: 34849114
  28. 28

    Eosinophilic fasciitis: experience with a patient and review of the potential mimics.

    Dandeniya C, Fifield M, Lebus C, Shenker N

    Acute medicine 2021; (20(4)):282-285 doi:10.52964/AMJA.0879.

    PMID: 35072386
  29. 29

    Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab.

    Zampeli E, Zervas E

    Mediterranean journal of rheumatology 2021; (32(4)):376-377 doi:10.31138/mjr.32.4.376.

    PMID: 35128334
  30. 30

    Eosinophilia complicated with venous thromboembolism: A case report.

    Su WQ, Fu YZ, Liu SY, et al.

    World journal of clinical cases 2022; (10(6)):1952-1960 doi:10.12998/wjcc.v10.i6.1952.

    PMID: 35317148
  31. 31

    Management of Raynaud's phenomenon in systemic sclerosis-a practical approach.

    Fernández-Codina A, Cañas-Ruano E, Pope JE

    Journal of scleroderma and related disorders 2019; (4(2)):102-110 doi:10.1177/2397198318823951.

    PMID: 35382396
  32. 32

    Refractory eosinophilic fasciitis successfully treated with infliximab: A case report.

    Śmigielska P, Czarny J, Kowalski J, et al.

    Journal of scleroderma and related disorders 2021; (6(2)):211-213 doi:10.1177/23971983211004399.

    PMID: 35386741
  33. 33

    Eosinophilic Fasciitis and Smoldering Multiple Myeloma: An Exceptional Association in Young Adults.

    Jabbouri R, Bouanani N, Aniq Filali R, Aasfara J

    Cureus 2022; (14(4)):e23896 doi:10.7759/cureus.23896.

    PMID: 35530826
  34. 34

    Raynaud's Phenomenon with Focus on Systemic Sclerosis.

    Maciejewska M, Sikora M, Maciejewski C, et al.

    Journal of clinical medicine 2022; (11(9)) doi:10.3390/jcm11092490.

    PMID: 35566614
  35. 35

    MRI Findings of Eosinophilic Fasciitis.

    Kubincová M, Vanhoenacker FM

    Journal of the Belgian Society of Radiology 2022; (106(1)):48 doi:10.5334/jbsr.2805.

    PMID: 35651918
  36. 36

    An unusual case of eosinophilia, myalgia and skin contractures: Shulman's disease revisited.

    Anadure RK, Shankar S, Mohimen A, et al.

    Medical journal, Armed Forces India 2022; (78(Suppl 1)):S273-S276 doi:10.1016/j.mjafi.2019.12.006.

    PMID: 36147388
  37. 37

    Eosinophilic Fasciitis Without Skin Sclerosis.

    Komori K, Rokutanda R

    The Journal of rheumatology 2023; (50(7)):963-964 doi:10.3899/jrheum.220600.

    PMID: 36455945
  38. 38

    [Paraneoplastic syndromes in rheumatology].

    Strunz PP, Schmalzing M

    Zeitschrift fur Rheumatologie 2023; (82(3)):212-219 doi:10.1007/s00393-022-01314-1.

    PMID: 36690750
  39. 39

    Eosinophilic Fasciitis: Current and Remaining Challenges.

    Mazilu D, Boltașiu Tătaru LA, Mardale DA, et al.

    International journal of molecular sciences 2023; (24(3)) doi:10.3390/ijms24031982.

    PMID: 36768300
  40. 40

    Eosinophilic fasciitis following SARS-CoV-2 vaccination.

    Antuña VL, Puchades F, Tapial JM, et al.

    JAAD case reports 2023; (36()):11-14 doi:10.1016/j.jdcr.2022.11.038.

    PMID: 37131494
  41. 41

    Groove sign in eosinophilic fasciitis.

    Li X, Ma DL

    The Medical journal of Australia 2023; (219(1)):15 doi:10.5694/mja2.51983.

    PMID: 37211616
  42. 42

    Eosinophilic fasciitis difficult to differentiate from scleroderma: A case report.

    Lan TY, Wang ZH, Kong WP, et al.

    World journal of clinical cases 2023; (11(13)):3092-3098 doi:10.12998/wjcc.v11.i13.3092.

    PMID: 37215414
  43. 43

    Eosinophilic Fasciitis Presenting as Chronic Nonspecific Symptoms in a Young Adult.

    Khaleel M, Ayyad M, Khalil NCN, et al.

    Oxford medical case reports 2023; (2023(12)):omad131 doi:10.1093/omcr/omad131.

    PMID: 38145270
  44. 44

    Eosinophilic Fasciitis Illustrated by 18 F-FDG PET/CT.

    Fevrier A, Dufour PA

    Clinical nuclear medicine 2024; (49(4)):e188-e190 doi:10.1097/RLU.0000000000005094.

    PMID: 38377376
  45. 45

    Eosinophilic Fasciitis in a 68-Year-Old Female.

    Chittipolu S, Kennard JL, Nahar L

    Cureus 2024; (16(2)):e53908 doi:10.7759/cureus.53908.

    PMID: 38465140
  46. 46

    A difficult diagnosis of eosinophilic fasciitis: A case report.

    Mihailescu M, Abbas M

    SAGE open medical case reports 2024; (12()):2050313X241231384 doi:10.1177/2050313X241231384.

    PMID: 38665934
  47. 47

    Eosinophilic fasciitis: unraveling the clinical tapestry of a rare case and review of literature.

    Cherim A, Bastian AE, Popp CG, et al.

    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2024; (65(2)):341-347 doi:10.47162/RJME.65.2.22.

    PMID: 39020550
  48. 48

    Pediatric eosinophilic fasciitis: similarities and differences with adult forms.

    César T, Giovannini D, Deroux A, et al.

    European journal of pediatrics 2025; (184(2)):156 doi:10.1007/s00431-025-05981-5.

    PMID: 39875648
  49. 49

    Treatment and Monitoring of Eosinophilic Fasciitis.

    Selva-O'Callaghan A, Trallero-Araguás E, Gil-Vila A, et al.

    Current treatment options in rheumatology 2025; (11()) doi:10.1007/s40674-024-00222-6.

    PMID: 40115529
  50. 50

    Immune checkpoint inhibitor-related eosinophilic fasciitis: 3 case reports with literature review.

    Biteau M, Sibaud V, Maria A, et al.

    La Revue de medecine interne 2025; (46(7)):377-385 doi:10.1016/j.revmed.2025.05.004.

    PMID: 40399177
  51. 51

    Eosinophilic Fasciitis: New Developments and Future Directions.

    Huynh M, Bogdanski E, Fleshman T, et al.

    International journal of dermatology 2025; (64(8)):1356-1370 doi:10.1111/ijd.17809.

    PMID: 40452121
  52. 52

    Diagnosis and treatment of early eosinophilic fasciitis: a case report.

    Ma J, Cai Y, Shao H, et al.

    Journal of medical case reports 2025; (19(1)):373 doi:10.1186/s13256-025-05440-7.

    PMID: 40731023
  53. 53

    Nivolumab-Induced Fasciitis Mimicking Scleroderma: A Diagnostic Challenge.

    Jannat R, Kshatri M, Thapa R

    Cureus 2025; (17(8)):e90484 doi:10.7759/cureus.90484.

    PMID: 40978900
  54. 54

    Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder Cancer.

    Oke I, Lenert A, Swick BL, Lenert P

    The American journal of case reports 2025; (26()):e948323 doi:10.12659/AJCR.948323.

    PMID: 41016045
  55. 55

    The utility of rituximab in patients with eosinophilic fasciitis: case series from an Australian tertiary multidisciplinary clinic.

    Ali SB, Khoo T, Marshman G, et al.

    Clinical rheumatology 2026; (45(1)):559-572 doi:10.1007/s10067-025-07850-w.

    PMID: 41331198
  56. 56

    Idiopathic inflammatory myopathies: a comprehensive review, new concepts on diagnostic imaging and whole-body MRI.

    Fagundes MDC, Gonçalves DVC, Shinjo SK, et al.

    European radiology 2026; (36(5)):4218-4232 doi:10.1007/s00330-025-12230-8.

    PMID: 41441994